Tag: Cancer: Throat
Provider Volume Affects Outcome in IMRT for Head, Neck Cancer
Improved survival for patients treated by higher-volume radiation oncologists
Time to Tx Initiation Impacts Survival in Head, Neck Cancer
Lower overall survival for time to treatment initiation of more than 46 to 52 days
Suicide Risk Up for Head, Neck Cancer Patients
Dependence on breathing tubes, feeding tubes might play a part in despair
Loss of Heterozygosity Validated As Marker for Oral Cancer
EGFR inhibitor erlotinib doesn't improve cancer-free survival in high-risk LOH-positive patients
Transoral Robotic Surgery Feasible for Oropharyngeal SCC
Results encouraging, with clear margins in 33 of 35 patients; 13 patients spared from adjuvant tx
Neuromuscular Stimulation Doesn’t Aid Dysphagia Patients
Combining NMES with swallow exercises in head and neck cancer patients not helpful
ASTRO: Less Treatment Effective in HPV-Related Oropharynx CA
Lower doses of chemotherapy, radiation may also reduce unwanted side effects
High-Dose Hypofractionated RT Palliative in Head, Neck Cancer
Meaningful palliative effect for 63 percent of patients, lasting for median of 4.6 months
No Specific Findings to ID Recurrence in Head and Neck CA
No definite index of symptoms or signs indicating local recurrence, second primary malignancy
Hematologic Markers Predict Nasopharyngeal Cancer Survival
High neutrophil-lymphocyte, platelet-lymphocyte ratios tied to shorter survival
